Geode Capital Management’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-21,826
| Closed | -$3.81K | – | 4871 |
|
|
2023
Q1 | $3.81K | Sell |
21,826
-140,045
| -87% | -$24.4K | ﹤0.01% | 4794 |
|
|
2022
Q4 | $64K | Sell |
161,871
-379
| -0.2% | -$150 | ﹤0.01% | 4528 |
|
|
2022
Q3 | $126K | Buy |
162,250
+631
| +0.4% | +$490 | ﹤0.01% | 4457 |
|
|
2022
Q2 | $465K | Sell |
161,619
-135,470
| -46% | -$390K | ﹤0.01% | 3810 |
|
|
2022
Q1 | $1.86M | Buy |
297,089
+42,555
| +17% | +$267K | ﹤0.01% | 3292 |
|
|
2021
Q4 | $2.84M | Buy |
254,534
+24,593
| +11% | +$274K | ﹤0.01% | 3194 |
|
|
2021
Q3 | $3.75M | Buy |
229,941
+23,364
| +11% | +$381K | ﹤0.01% | 3076 |
|
|
2021
Q2 | $3.83M | Buy |
206,577
+82,905
| +67% | +$1.54M | ﹤0.01% | 3056 |
|
|
2021
Q1 | $1.86M | Buy |
123,672
+50,215
| +68% | +$757K | ﹤0.01% | 3282 |
|
|
2020
Q4 | $2.37M | Buy |
+73,457
| New | +$2.37M | ﹤0.01% | 2988 |
|